IL1RN and neoplasm: To assess whether IL1RN editing alters the tumor-modulatory potential of the macrophage secretome, we collected supernatants from CTRL and sgIL1RN iMacs after 24 hours of IL-1β stimulation, which were differentially enriched in IL-1RN, IL-1β, and IP-10 (fig.